borderline significantp = 0.014
A borderline significant difference was observed in the use of statins, with a higher prevalence in the non-severe COVID-19 group compared to the control group ( p = 0.014).
A borderline significant difference was observed in the use of statins, with a higher prevalence in the non-severe COVID-19 group compared to the control group ( p = 0.014).